List of Treatments for Lymphoma

Neulasta (Pegfilgrastim)

Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by… read more

Nutrition

Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with lymphoma, good nutrition can help you recover from treatment, reduce treatment side effects, support bone health,… read more

Oncovin (Vincristine)

The Oncovin brand name has been discontinued in the U.S. Generic alternatives may be available.

Overview
Oncovin is a prescription medication used to treat several types of cancer including Hodgkin lymphoma, non-Hodgkin…

Ontak (Denileukin diftitox)

Overview
Ontak is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with persistent or recurrent cutaneous T-cell lymphoma. Ontak is also referred to by its drug name,… read more

Opdivo (Nivolumab)

Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma. Opdivo is indicated in cases where lymphoma has relapsed or progressed… read more

Plasmapheresis (Plasma exchange)

Overview
In some types of lymphoma – lymphoplasmacytic lymphoma, also known as Waldenström macroglobulinaemia, and multiple myeloma – cancer cells can secrete abnormal proteins. When abnormal proteins accumulate, they… read more

Polivy (Polatuzumab vedotin-piiq)

Overview

Polivy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory diffuse large B-cell lymphoma not otherwise specified. Polivy is indicated for… read more

Poteligeo (Mogamulizumab-kpkc)

Overview
Poteligeo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory mycosis fungoides (MF) and adults with relapsed or refractory Sézary syndrome… read more

Radiation therapy

Overview
Radiation therapy (also called RT or radiotherapy) is used to treat Hodgkins lymphoma (HL) and non-Hodgkins lymphoma (NHL). Radiation therapy is more likely to be used in cases where lymphoma is limited to one… read more

Revlimid (Lenalidomide)

Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Revlimid is often combined with other drugs such as a… read more

Riabni (Rituximab-Arrx)

Overview
Riabni (rituximab-arrx) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that affects the lymphatic system (part of the immune system…

Rituxan (Rituximab)

Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma. Rituxan may be prescribed alone or in combination with other antilymphoma drugs. Rituxan may… read more

Rituxan Hycela (Rituximab/hyaluronidase human)

Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and chronic lymphocytic leukemia (CLL). Rituxan… read more

Ruxience (Rituximab-Pvvr)

Overview
Ruxience (rituximab-pvvr) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that starts in the lymphatic system (part of the immune…

Tazverik (Tazemetostat)

Overview
Tazverik is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma in adults and children 16 years and older whose tumors are positive for the EZH2 mutation and… read more

Tecartus (Brexucabtagene autoleucel)

Overview

Tecartus is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory mantle cell lymphoma (MCL) in adults. Tecartus is only available through a… read more

Thalomid (Thalidomide)

Overview
Thalomid, also known by its drug name thalidomide, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat, in conjunction with dexamethasone, newly diagnosed multiple… read more

Treanda (Bendamustine)

Overview
Treanda is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Treanda is sometimes prescribed… read more

Truxima (Rituximab-Abbs)

Overview
Truxima (rituximab-abbs) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that starts in the lymphatic system (part of the immune…

Ukoniq (Umbralisib)

Overview
Ukoniq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with follicular lymphoma who have received at least three previous therapies and adults with marginal zone… read more

Velcade (Bortezomib)

Overview
Velcade, also known by its drug name bortezomib, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Velcade is often… read more

Venclexta (Venetoclax)

Overview
Venclexta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and adults over 75 years old… read more

Vinblastine

The Vinblastine brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Vinblastine is a prescription medication used to treat several types of cancer including…

Xalkori (Crizotinib)

Overview
Xalkori is approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers that are positive for anaplastic lymphoma kinase (ALK) or ROS1. Among its specific indications, it’s approved for…

Xpovio (Selinexor)

Overview
Xpovio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have been treated with at least two… read more

Yescarta (Axicabtagene ciloleucel)

Overview
Yescarta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Yescarta is indicated when lymphoma is relapsed or refractory and at least two… read more

Zevalin (Ibritumomab tiuxetan)

Overview
Zevalin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma (NHL). Specifically, Zevalin is indicated for use in low-grade or follicular B-cell lymphoma… read more

Zolinza (Vorinostat)

Overview
Zolinza is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat skin symptoms in people with cutaneous T-cell lymphoma (CTCL). Zolinza is indicated for use in patients when… read more

Zydelig (Idelalisib)

Overview
Zydelig is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed cases of follicular B-cell non-Hodgkin lymphoma, small lymphocytic lymphoma (SLL), and chronic… read more

Zynlonta (Loncastuximab Tesirine-Lpyl)

Overview
Zynlonta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. This includes…